No new Ebola infections have been detected in Uganda for 42 days, and so on Wednesday, the World Health Organization and the Ugandan Ministry of Health officially declared that the country’s ...

The research, based on data from the massive 2018-2020 Ebola Zaire outbreak in the Democratic Republic of the Congo, showed that the risk of dying of Ebola was halved among people who had been ...

Three candidate vaccines in development for the Ebola Zaire strain were sent to Uganda, with the first arriving on December 8, to be evaluated in a clinical trial being run by the Makerere ...

During the 2014–16 Ebola outbreak, centered in West Africa and caused by the Ebola Zaire species, 11 people in the U.S. were treated for the virus. Of the 11, ...

Source Reference: PREVAC Study Team "Randomized trial of vaccines for Zaire Ebola virus disease" N Engl J Med 2022; DOI: 10.1056/NEJMoa2200072. Share on Facebook. Opens in a new tab or window.

Ebola Zaire is the most common cause of outbreaks, followed by Ebola Sudan. But there are long stretches between outbreaks of the latter, making it difficult to test drugs or vaccines for this ...

The Ebola vaccine rVSV-ZEBOV was approved by the FDA in 2019 but only protects against Zaire ebolavirus, or Ebola virus proper, not any of the other three human-contracted Ebola-causing viruses.

Ebola spreads through contact with the bodily fluids of an infected person and has a fatality rate of about 50%. More than 11,300 people died during the 2013-2016 outbreak in West Africa. 5 ...

The first outbreak of Ebola occurred in 1976, at which time people were infected in in a western equatorial province of Sudan and in a nearby region of northern Zaire.

For our calculations, we tested 100 values of R 0 sampled evenly across each strain’s range: from 1.36 to 4.71 for Ebola Zaire outbreaks and 1.34 to 2.7 for Ebola Sudan outbreaks.